These include acute respiratory distress syndrome (ARDS), asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, idiopathic pulmonary fibrosis, chronic bronchitis and various viral and bacterial infections [3]
Similar content being viewed by others Background Severe cutaneous adverse reactions (SCARs) are clinically classified into several subtypes, including drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and acute generalized exanthematous pustulosis (AGEP)
The emerging nature of astrocyte diversity
So whatever you're experiencing there is very nicely supported by the data
The second is that the study looked exclusively at people with diabetes, as theyre at a higher risk of developing mental health disorders making it unclear if these potential benefits would apply to people taking GLP-1s for other reasons